{"id":"W2296991627","doi":"10.1200/jco.2014.32.15_suppl.tps1144","title":"A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Enzalutamide; Medicine; Androgen receptor; Triple-negative breast cancer; Tolerability; Breast cancer; Clinical endpoint; Oncology; Cancer; Internal medicine; Adverse effect; Clinical trial; Prostate cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002006402,0.002135092,0.003038264,0.0005811202,0.0003896973,0.001068183,0.0009126098,0.001442676,0.006606325],"category_scores_gemma":[0.001373097,0.0007729498,0.001334406,0.0004368049,0.0009145148,0.001145202,0.0004063844,0.002488431,0.001340836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000893403,"about_ca_system_score_gemma":0.001701676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009262732,"about_ca_topic_score_gemma":0.002445982,"domain_scores_codex":[0.9994759,0.0002697342,0.000022046,0.00008642123,0.00005111369,0.00009485921],"domain_scores_gemma":[0.9992871,0.0001221145,0.0001343207,0.0000658987,0.00005344269,0.0003370654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9055329,0.03765731,0.002097697,0.0006135303,0.0009588519,0.0001335324,0.0001495867,0.001392707,0.01083535,0.0001608915,0.002110112,0.0383574],"study_design_scores_gemma":[0.7676285,0.2257147,0.003337389,0.00001905999,0.0002980925,0.00009917236,0.00003656843,0.0006999922,0.0006319022,0.000166697,0.001345724,0.00002218134],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811671,0.002640025,0.001204079,0.0007334909,0.00031706,0.008521491,0.002119693,0.0002027335,0.003094306],"genre_scores_gemma":[0.9752982,0.002264988,0.002741016,0.001479167,0.0003276157,0.009873739,0.002385539,0.00005624773,0.005573531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006606325,"threshold_uncertainty_score":0.02210033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02232127594832286,"score_gpt":0.3810981850185713,"score_spread":0.3587769090702485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}